Based on in vitro models of NASH, adiponectin may also exert beneficial effects by acting directly on the liver to reduce hepatic stellate cell activation and migration (254–256). The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatohepatitis.